Impact of Transcranial Direct Current Stimulation in Pain, Fatigue, and Health Quality of Life of Patients with Idiopathic Inflammatory Myopathies: A Randomized, Double-Blind, Sham-Controlled Crossover Clinical Trial
Table 6
Data regarding the perception and impact of pain before and after interventions.
tDCS ()
Sham ()
Pre
Post
ES
Pre
Post
ES
VASp moment (0-10)
1.5 (0.0-5.0)
0.0 (0.0-0.3)
-0.33
0.0 (0.0-5.5)
4.0 (0.0-5.0)
0.17
0.589
0.025
0.934
VASp minimum (0-10)
2.0 (1.0-3.0)
0.5 (0.0-1.0)
-0.60
3.0 (1.0-5.0)
1.0 (1.0-3.0)
-0.54
0.097
0.353
0.432
VASp average (0-10)
3.7 (2.2-5.5)
0.0 (0.0-2.2)
-0.79
3.0 (1.0-5.0)
2.0 (1.5-5.0)
-0.14
0.097
0.017
0.004
VASp maximum (0-10)
6.0 (4.0-8.2)
1.0 (0.0-4.0)
-1.10
5.0 (1.0-8.0)
4.0 (0.0-6.5)
-0.24
0.016
0.083
0.023
Brief pain impact
VASp general activity (0-10)
1.0 (0.0-8.2)
0.0 (0.0-3.2)
-0.45
5.0 (1.0-8.5)
3.0 (0.0-5.0)
-0.35
0.251
0.053
0.027
VASp disposition (0-10)
1.0 (0.0-6.2)
0.0 (0.0-1.1)
-0.39
3.0 (0.0-4.5)
3.0 (0.0-5.0)
-0.1
0.748
0.021
0.37
VASp walking ability (0-10)
0.5 (0.0-6.5)
0.0 (0.0-0.0)
-0.49
0.0 (0.0-7.5)
0.0 (0.0-5.0)
-0.16
0.312
0.151
0.039
VASp work (0-10)
0.0 (0.0-8.0)
0.0 (0.0-0.5)
-0.50
4.0 (0.0-6.0)
0.0 (0.0-5.0)
-0.29
0.293
0.297
0.002
VASp interpersonal relationship (0-10)
0.0 (0.0-4.0)
0.0 (0.0-0.0)
-0.31
0.0 (0.0-6.0)
0.0 (0.0-2.5)
-0.29
0.381
0.211
0.089
VASp sleep (0-10)
0.0 (0.0-4.2)
0.0 (0.0-3.1)
-0.10
0.0 (0.0-7.0)
0.0 (0.0-4.0)
-0.24
0.787
0.571
0.063
VASp enjoyment of life (0-10)
0.0 (0.0-6.5)
0.0 (0.0-0.5)
-0.40
0.0 (0.0-6.0)
0.0 (0.0-3.5)
-0.17
0.408
0.073
0.029
McGill score (0-84)
32 (1.5-38.0)
0.0 (0.0-13.4)
-0.78
26 (0.0-37)
5.0 (0.0-19.2)
-0.54
0.047
0.058
0.447
Data are presented as median (25th-75th). VASp: visual pain scale; tDCS: transcranial direct current stimulation.
